Table 1.

Human Immunodeficiency Virus (HIV) Diagnoses Among Persons Aged 13 Years or Older in the United States

	HIV Diagnosis Rate/100 000 Population by Year of Diagnosis										% Change	EAPC (95% CI)
	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011
Sex
Male	35.8	33.5	33.2	31.4	31.2	31.5	30.3	28.4	26.9	26.1	−27.1	−3.1 (−3.2 to −3.0)
Female	13.0	11.7	11.2	10.3	10.1	9.9	9.2	8.1	7.2	6.6	−49.2	−6.6 (−6.8 to −6.4)
Age group, y
13–24	12.5	12.4	13.2	13.6	14.8	16.1	17.3	17.5	17.6	17.3	38.4	4.6 (4.4 to 4.9)
25–34	39.8	36.0	35.5	33.5	32.6	32.9	31.8	29.5	28.5	27.8	−30.2	−3.6 (−3.7 to −3.4)
35–44	46.2	42.7	41.2	37.6	36.6	34.8	31.3	28.0	25.0	22.9	−50.4	−7.1 (−7.3 to −7.0)
45–54	25.9	24.7	23.9	23.0	22.9	23.2	22.0	19.8	18.3	17.8	−31.3	−3.8 (−4.0 to −3.6)
≥55	6.2	5.9	6.2	5.8	5.7	6.0	5.9	5.3	5.0	4.8	−22.6	−2.5 (−2.8 to −2.1)
Race/ethnicitya
American Indian/Alaska Native	12.9	12.5	11.7	11.7	10.5	10.7	11.3	10.2	11.3	10.0	−22.5	−2.3 (−3.8 to −0.8)
Asian	6.2	6.3	6.5	6.0	6.3	7.2	7.0	6.4	5.8	6.4	3.2	0.1 (−0.7 to 1.0)
Black	99.4	90.9	89.1	81.7	80.3	80.1	79.0	71.6	66.7	62.6	−37.0	−4.4 (−4.6 to −4.3)
Hispanicb	37.5	34.3	31.9	30.0	30.3	29.7	27.3	25.5	22.6	22.0	−41.3	−5.4 (−5.6 to −5.2)
Native Hawaiian/other Pacific Islander	16.1	26.7	20.4	20.8	26.3	21.3	22.0	21.8	14.3	16.7	3.7	−2.6 (−5.0 to −0.1)
White	10.1	9.5	9.4	9.0	8.8	8.8	8.1	7.5	7.2	6.9	−31.7	−4.0 (−4.1 to −3.8)
Multiple races	52.5	43.1	45.8	47.5	39.4	42.1	38.1	33.2	25.7	22.5	−57.1	−7.7 (−8.3 to −7.1)
Total	24.1	22.3	21.9	20.6	20.4	20.4	19.6	18.0	16.8	16.1	−33.2	−4.0 (−4.1 to −3.9)
No. of HIV Diagnoses by Transmission Category and Year of Diagnosisc
Males
MTM sexual contact	26 021	25 251	26 240	25 838	26 313	27 614	27 466	26 685	26 035	26 033	0	0.3 (0.1 to 0.5)
Injection drug use	6004	5199	4592	4064	3860	3424	2937	2436	2102	1795	−70.1	−11.8 (−12.5 to −11.1)
Both of the above	2850	2587	2473	2320	2085	1956	1732	1513	1397	1211	−57.5	−8.6 (−9.4 to −7.8)
Heterosexual contactd	5980	5628	5546	5040	5187	5266	5043	4508	4123	3910	−34.6	−4.0 (−4.6 to −3.5)
Othere	155	118	107	83	79	52	60	39	37	31	−80.0	−16.3 (−23.0 to −9.0)
Subtotal	41 010	38 783	38 958	37 345	37 524	38 313	37 238	35 181	33 694	32 980	−27.1	−3.1 (−3.2 to −3.0)
Females
Injection drug use	3892	3324	3060	2666	2443	2215	1981	1658	1358	1218	−68.7	−11.5 (−12.4 to −10.6)
Heterosexual contactd	11 695	10 896	10 651	10 094	10 169	10 262	9836	8755	8094	7507	−35.8	−4.1 (−4.4 to −3.8)
Othere	119	103	89	73	58	42	32	22	17	15	−87.4	−20.4 (−28.4 to −11.6)
Subtotal	15 705	14 323	13 800	12 834	12 670	12 519	11 850	10 435	9470	8740	−49.2	−6.6 (−6.8 to −6.4)
Total	56 715	53 106	52 758	50 179	50 194	50 832	49 088	45 616	43 164	41 720	−33.2	−4.0 (−4.1 to 3.9)

Abbreviations: EAPC, estimated annual percentage change; MTM, male-to-male.

^aDefinitions based on standards for the classification of federal data from the US Office of Management and Budget.

^bCan be of any race.

^cRates not provided due to lack of denominator data for risk populations from the US Census Bureau.

^dIndicates contact with a person known to have, or to be at high risk for, HIVinfection.

^eIncludes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.